Dynamic Technology Lab’s Intellia Therapeutics NTLA Stock Holding History

Dynamic Technology Lab’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,287	Closed	-$145K	–	968
2026 Q1	$145K	Buy	+11,287	New	+$144K	0.02%	773
2023 Q4	–	Sell	-12,280	Closed	-$388K	–	1296
2023 Q3	$388K	Buy	12,280 +6,900	+128%	+$268K	0.04%	573
2023 Q2	$219K	Buy	+5,380	New	+$218K	0.03%	806
2022 Q4	–	Sell	-8,130	Closed	-$455K	–	1382
2022 Q3	$455K	Buy	+8,130	New	+$504K	0.04%	667
2022 Q2	–	Sell	-3,470	Closed	-$252K	–	1407
2022 Q1	$252K	Buy	+3,470	New	+$294K	0.03%	864
2017 Q3	–	Sell	-10,454	Closed	-$167K	–	1274
2017 Q2	$167K	Buy	+10,454	New	+$146K	0.03%	907

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Dynamic Technology Lab's NTLA Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Intellia Therapeutics (NTLA) in Q2 2026, closing a stake of 11,287 shares — an estimated $145K sold.

Dynamic Technology Lab first reported a position in NTLA in Q2 2017 and held it in 6 quarters. The position peaked at $455K in Q3 2022. 329 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

Dynamic Technology Lab reported no remaining Intellia Therapeutics position as of Q2 2026 after selling out during the quarter.
Dynamic Technology Lab sold 11,287 Intellia Therapeutics shares in Q2 2026, an estimated $145K.
Dynamic Technology Lab first reported a position in Intellia Therapeutics in Q2 2017 and held it in 6 quarters.
Dynamic Technology Lab's Intellia Therapeutics position peaked at $455K in Q3 2022.
329 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.